pubmed-article:14754895 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14754895 | lifeskim:mentions | umls-concept:C0026597 | lld:lifeskim |
pubmed-article:14754895 | lifeskim:mentions | umls-concept:C1422064 | lld:lifeskim |
pubmed-article:14754895 | lifeskim:mentions | umls-concept:C1167622 | lld:lifeskim |
pubmed-article:14754895 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
pubmed-article:14754895 | lifeskim:mentions | umls-concept:C0043309 | lld:lifeskim |
pubmed-article:14754895 | lifeskim:mentions | umls-concept:C0007382 | lld:lifeskim |
pubmed-article:14754895 | lifeskim:mentions | umls-concept:C0678594 | lld:lifeskim |
pubmed-article:14754895 | pubmed:issue | 17 | lld:pubmed |
pubmed-article:14754895 | pubmed:dateCreated | 2004-4-19 | lld:pubmed |
pubmed-article:14754895 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:abstractText | The angiotensin-converting enzyme (ACE)-related carboxypeptidase, ACE2, is a type I integral membrane protein of 805 amino acids that contains one HEXXH + E zinc-binding consensus sequence. ACE2 has been implicated in the regulation of heart function and also as a functional receptor for the coronavirus that causes the severe acute respiratory syndrome (SARS). To gain further insights into this enzyme, the first crystal structures of the native and inhibitor-bound forms of the ACE2 extracellular domains were solved to 2.2- and 3.0-A resolution, respectively. Comparison of these structures revealed a large inhibitor-dependent hinge-bending movement of one catalytic subdomain relative to the other ( approximately 16 degrees ) that brings important residues into position for catalysis. The potent inhibitor MLN-4760 ((S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol4-yl]-ethylamino]-4-methylpentanoic acid) makes key binding interactions within the active site and offers insights regarding the action of residues involved in catalysis and substrate specificity. A few active site residue substitutions in ACE2 relative to ACE appear to eliminate the S(2)' substrate-binding subsite and account for the observed reactivity change from the peptidyl dipeptidase activity of ACE to the carboxypeptidase activity of ACE2. | lld:pubmed |
pubmed-article:14754895 | pubmed:language | eng | lld:pubmed |
pubmed-article:14754895 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14754895 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14754895 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14754895 | pubmed:month | Apr | lld:pubmed |
pubmed-article:14754895 | pubmed:issn | 0021-9258 | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:FisherMartinM | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:TangJinJ | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:ParsonsThomas... | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:WilliamsDavid... | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:DalesNatalie... | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:PataneMichael... | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:PrasadSridhar... | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:TowlerPaulP | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:StakerBartB | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:MenonSaurabhS | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:RyanDominicD | lld:pubmed |
pubmed-article:14754895 | pubmed:author | pubmed-author:PantolianoMic... | lld:pubmed |
pubmed-article:14754895 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14754895 | pubmed:day | 23 | lld:pubmed |
pubmed-article:14754895 | pubmed:volume | 279 | lld:pubmed |
pubmed-article:14754895 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14754895 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14754895 | pubmed:pagination | 17996-8007 | lld:pubmed |
pubmed-article:14754895 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:meshHeading | pubmed-meshheading:14754895... | lld:pubmed |
pubmed-article:14754895 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:14754895 | pubmed:articleTitle | ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. | lld:pubmed |
pubmed-article:14754895 | pubmed:affiliation | Drug Discovery and Protein Sciences, Millennium Pharmaceuticals, Incorporated, Cambridge, Massachusetts 02139, USA. | lld:pubmed |
pubmed-article:14754895 | pubmed:publicationType | Journal Article | lld:pubmed |
entrez-gene:59272 | entrezgene:pubmed | pubmed-article:14754895 | lld:entrezgene |
entrez-gene:302668 | entrezgene:pubmed | pubmed-article:14754895 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:14754895 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14754895 | lld:pubmed |